Scholar Rock Holding (SRRK) Retained Earnings (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Retained Earnings of $690000.0 in Q1 2026, up 100.05% quarter-over-quarter from -$1.3 billion in Q4 2025, and up 100.07% on a YoY basis from $344880.7 in Q1 2025.
Scholar Rock Holding (SRRK) Retained Earnings (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Retained Earnings history runs 10 years deep, the most recent figure standing at $690000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 100.07% year-over-year to $690000.0; the TTM figure through Mar 2026 stood at $690000.0 (up 100.07% YoY), while the FY2025 annual figure was -$1.3 billion, down 813008.75% from the prior year.
- Retained Earnings was $690000.0 for Q1 2026 at Scholar Rock Holding, up from -$1.3 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $690000.0 in Q1 2026 to a low of -$1.3 billion in Q4 2025.
- Historically, Retained Earnings has averaged -$433.7 million across 5 years, with a median of -$510.6 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings sank 1994776.0% in 2025, then jumped 100.07% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$510.6 million in 2022, then plunged by 32.47% to -$676.4 million in 2023, then soared by 100.02% to $160000.0 in 2024, then tumbled by 813008.75% to -$1.3 billion in 2025, then jumped by 100.05% to $690000.0 in 2026.
- The last three Retained Earnings figures came in at $690000.0 (Q1 2026), -$1.3 billion (Q4 2025), and $117000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 690,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 690,000.00 |
| Dec 31, 2025 | -1.30 Bn |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | -997.44 Mn |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | -856.26 Mn |
| Jun 30, 2024 | -791.80 Mn |
| Mar 31, 2024 | -50,000.00 |
| Dec 31, 2023 | -676.42 Mn |
| Sep 30, 2023 | -630.30 Mn |
| Jun 30, 2023 | -587.94 Mn |
| Mar 31, 2023 | -550.01 Mn |
| Dec 31, 2022 | -510.63 Mn |
| Sep 30, 2022 | -471.38 Mn |
| Jun 30, 2022 | -79,000.00 |
| Mar 31, 2022 | -152,000.00 |
| Dec 31, 2021 | -35,000.00 |
| Sep 30, 2021 | -340.22 Mn |
| Jun 30, 2021 | 9,000.00 |